Sequential and Hybrid Therapies for H Pylori Infection

NCT01085786 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: 14-day sequential treatment
DRUG: 14-day hybrid treatment

Sponsor

Kaohsiung Veterans General Hospital.

Collaborators

[object Object]
[object Object]